Paul Balderes

1.9k total citations
32 papers, 1.2k citations indexed

About

Paul Balderes is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Paul Balderes has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Oncology. Recurrent topics in Paul Balderes's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (8 papers) and Angiogenesis and VEGF in Cancer (6 papers). Paul Balderes is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (8 papers) and Angiogenesis and VEGF in Cancer (6 papers). Paul Balderes collaborates with scholars based in United States and China. Paul Balderes's co-authors include Dale L. Ludwig, Zhenping Zhu, Haifan Zhang, Xenia Jimenez, Daniel J. Hicklin, Rajiv Bassi, Peter Böhlen, Larry Witte, James R. Tonra and Dan Lu and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Molecular Biology.

In The Last Decade

Paul Balderes

32 papers receiving 1.1k citations

Peers

Countries citing papers authored by Paul Balderes

Since Specialization

Citations

This map shows the geographic impact of Paul Balderes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Balderes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Balderes more than expected).

Fields of papers citing papers by Paul Balderes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Balderes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Balderes. The network helps show where Paul Balderes may publish in the future.

Co-authorship network of co-authors of Paul Balderes

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Balderes. A scholar is included among the top collaborators of Paul Balderes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Balderes. Paul Balderes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth 2014 ·Cancer Biology & Therapy ·(unknown), Laura Brennan, (unknown), Marie Prewett, (unknown), Inga Duignan, Kelly M. Credille, (unknown), Marina Starodubtseva, (unknown), Yiwei Zhang, (unknown), Douglas Burtrum, Paul Balderes, Kris Persaud, David Surguladze, Nick Loizos, Keren Paz, Helen Kotanides	11
2	What can cell culture flocculation offer for antibody purification processes 2014 ·Yun Kang, Dale L. Ludwig, Paul Balderes	4
3	Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity 2013 ·mAbs ·Yang Shen, Lin Zeng, Aiping Zhu, (unknown), Dipa Patel, (unknown), (unknown), Stanley S. Ng, Kris Persaud, Yun Kang, Paul Balderes, David Surguladze, (unknown), Qinwei Zhou, Dale L. Ludwig, M D Snavely	16
4	The Structural Basis for the Function of Two Anti-VEGF Receptor 2 Antibodies 2011 ·Structure ·Matthew C. Franklin, Elizabeth Navarro, Yujie Wang, Sheetal Patel, (unknown), Yi Zhang, Kris Persaud, (unknown), Heather Griffith, Leyi Shen, Paul Balderes, Paul Kussie	44
5	Abstract #844: Anti-TGF beta receptor II antibody suppresses tumor growth and metastasis through inhibiting TGF beta autocrine stimulation of tumor cells and myeloid cells 2009 ·Cancer Research ·Zhaojing Zhong, (unknown), Kyla Driscoll Carroll, Michael Gregory, Rajiv Bassi, (unknown), (unknown), (unknown), Xenia Jimenez, (unknown), Kris Persaud, Paul Balderes, Dale L. Ludwig, Larry Witte, Zhenping Zhu, Yan Wu	1
6	Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody 2009 ·Neoplasia ·Juqun Shen, (unknown), Marie Prewett, (unknown), Haifan Zhang, Huiling Li, Xenia Jimenez, Dhanvanthri S. Deevi, (unknown), (unknown), Rajiv Bassi, Kris Persaud, (unknown), Paul Balderes, Nick Loizos, Dale L. Ludwig, James R. Tonra, Larry Witte, Zhenping Zhu	50
7	Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1 2008 ·Human Antibodies ·Dipa Patel, Paul Balderes, (unknown), Maxine Melchior, (unknown), Rajiv Bassi, Yan Wu, Heather Griffith, Xenia Jimenez, Dale L. Ludwig, Daniel J. Hicklin, Xiaoqiang Kang	19
8	An antibody directed against PDGF receptor β enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody 2007 ·Biochemical and Biophysical Research Communications ·Juqun Shen, (unknown), Haifan Zhang, James R. Tonra, Ling Rong, (unknown), Marie Prewett, Dhanvanthri S. Deevi, (unknown), David Surguladze, Xenia Jimenez, (unknown), Rajiv Bassi, Kai Zhou, Paul Balderes, (unknown), Nick Loizos, Dale L. Ludwig, Zhenping Zhu	32
9	Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member 2006 ·Cancer Research ·(unknown), Karen E. Rabenau, (unknown), Dan Lu, (unknown), Paul Balderes, (unknown), Rajiv Bassi, Marie Prewett, (unknown), Megan N. Thobe, Yuan Cheng, Yiwen Li, Daniel J. Hicklin, Zhenping Zhu, Susan E. Waltz, Michael J. Hayman, Dale L. Ludwig, Daniel S. Pereira	105
10	Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2 2006 ·Biochemical and Biophysical Research Communications ·Hua‐Quan Miao, (unknown), Xenia Jimenez, Elizabeth Navarro, Haifan Zhang, Dan Lu, Dale L. Ludwig, Paul Balderes, Zhenping Zhu	79
11	Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies 2006 ·Journal of Immunological Methods ·Juqun Shen, (unknown), Xenia Jimenez, Haifan Zhang, (unknown), (unknown), Paul Balderes, Dale L. Ludwig, Zhenping Zhu	23
12	Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth 2005 ·Leukemia ·Bart O. Williams, (unknown), (unknown), Desheng Lu, Xenia Jimenez, Hui Li, (unknown), Dale L. Ludwig, Paul Balderes, Luc de Witte, Yi Li, Z Zhu	18
13	A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity 2005 ·Journal of Biological Chemistry ·Dan Lu, Haifan Zhang, Henry Koo, James R. Tonra, Paul Balderes, Marie Prewett, (unknown), (unknown), Rajiv Bassi, (unknown), Dipa Patel, Xiaoqiang Kang, Dale L. Ludwig, Daniel J. Hicklin, Peter Böhlen, Larry Witte, Zhenping Zhu	146
14	Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature 2005 ·Blood ·Chad May, Jacqueline Doody, Rashed Abdullah, Paul Balderes, Xiaohong Xu, Chien Peter Chen, Zhenping Zhu, Lawrence Shapiro, Paul Kussie, Daniel J. Hicklin, Fang Liao, Peter Böhlen	80
15	Inhibitory Anti-FLT3 Antibodies Are Capable of Mediating Antibody-Dependent Cell-Mediated Cytotoxicity and Reducing Engraftment of Acute Myelogenous Leukemia Blasts in Nonobese Diabetic/Severe Combined Immunodeficient Mice 2005 ·Cancer Research ·Obdulio Piloto, Mark J. Levis, David L. Huso, Yiwen Li, Hongli Li, (unknown), Rajiv Bassi, Paul Balderes, Dale L. Ludwig, Larry Witte, Zhenping Zhu, Daniel J. Hicklin, Donald Small	42
16	Simultaneous Blockade of Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor Signaling Pathways in Cancer Cells with a Fully Human Recombinant Bispecific Antibody 2004 ·Journal of Biological Chemistry ·Dan Lu, Haifan Zhang, Dale L. Ludwig, (unknown), Xenia Jimenez, Douglas Burtrum, Paul Balderes, Meilin Liu, Peter Böhlen, Larry Witte, Zhenping Zhu	98
17	A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers 2004 ·Cancer Research ·Yan Wu, Zhaojing Zhong, Huiling Li, James Huber, Rajiv Bassi, Andrea T. Hooper, Bridget Finnerty, Xenia Jimenez, Henry Koo, Paul Balderes, Dale L. Ludwig, Paul Kussie, Larry Witte, Peter Böhlen, Daniel J. Hicklin	1
18	70 Therapeutic human monoclonal antibody targeting VEGFR-1 suppresses growth of human breast cancers 2004 ·European Journal of Cancer Supplements ·(unknown), Zhangfeng Zhong, (unknown), (unknown), Rosaria Bassi, Paul Balderes, James R. Tonra, D Ludwig, Peter Böhlen, Dan Hicklin	1
19	Di-diabody: a novel tetravalent bispecific antibody molecule by design 2003 ·Journal of Immunological Methods ·Dan Lu, Xenia Jimenez, Haifan Zhang, (unknown), Laura Brennan, Paul Balderes, Peter Böhlen, Larry Witte, Zhenping Zhu	31
20	Nucleotide sequence of korB, a replication control gene of broad host-range plasmid RK2 1987 ·Journal of Molecular Biology ·(unknown), Paul Balderes, David H. Figurski	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact